The Transition from a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk by Heba M Ismail (9568748)

“…This change was mostly attributable to change in the late AUC C-peptide response (i.e., 60-to-120-minute AUC C-peptide). Median Index60 values of  DPT-1 (1.44) and TNPTP (1.05) progressors to type 1 diabetes 1.5 years pre-diagnosis (time of transition from increasing to decreasing AUC C-peptide) were used as thresholds to identify individuals at high risk for type 1 diabetes in the full cohort at baseline (5-year risk of 0.75-0.88 for those above thresholds). …”

Decreasing trends in HbA1c are visible when using the average HbA1c for each dataset for T1Ds, but not T2Ds. by Hans F. Dias (14486401)

Effect of parameter <i>a</i> on the model equations by increasing and decreasing value of <i>a</i> to 25%. by Shakoor Ahmad (168711)

“…<p><b>(a)</b> By increasing the value ‘<i>a</i>’ from 0.107 to 0.134. <b>(b)</b> By decreasing the value ‘<i>a</i>’ from 0.107 to 0.08.…”

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

“…<p>GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value).</p>…”

CHIKV-infected primary joint tissue fibroblasts display decreased MHC-I cell surface expression. by Brian C. Ware (8544672)

<i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. by Justine Guguin (9088672)

Cells expressing nsP2 inefficiently present antigen and have decreased levels of cell surface MHC-I. by Brian C. Ware (8544672)

Pericentric heterochromatin structural integrity is disrupted in the absence of CFDP1 due to loss of core heterochromatin protein, HP1α and H3K9me3 marks. by Gokul Gopinathan (7930679)

“…<i>p</i> value (* < 0.05, ** < 0.01, *** < 0.001). …”

Decreased <i>Bgl-</i>FaNaC expression in the visceral ganglion following <i>S</i>. <i>mansoni</i> infection. by Laura C. Vicente-Rodríguez (16437803)

“…Dunnett’s <i>post hoc</i> test: *, <i>p</i> < 0.05. See values in <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0011249#pntd.0011249.t001" target="_blank">Table 1</a>. …”

Predictive value of RVT1 for the decreased RV ejection fraction (RVEF) and poor outcome in pulmonary arterial hypertension (PAH). by Ryotaro Asano (11767131)

“…<p>(a) Study profile. Thirty patients were enrolled (evaluating outcomes), and native T1 mapping using CMR and RHC was performed. …”

Cell-penetrating 15mer peptides decrease the proliferation and viability of cancer cells. by Pavan Kumar Puvvula (10495853)

Primers used in this study. by Hadi Alizadeh (20854757)

Subjects:

PLB is a target gene of miRNA 221. by Hongyu Li (1332669)

Subjects:

Decreased <i>Bgl-</i>FaNaC expression in the left parietal ganglion following <i>S</i>. <i>mansoni</i> infection. by Laura C. Vicente-Rodríguez (16437803)

“…<p><b>a-c:</b> Decreased <i>Bgl</i>-FaNaC hybridization on the dorsal surface of the left parietal ganglion in infected specimens. …”

Cabozantinib significantly decreases tumor volume and prolongs survival in SCNPC PDX models. by Mark P. Labrecque (10011469)

CD5-2 decreases established CCM lesions in the hindbrain of <i>Ccm2</i>^<i>ECKO</i> mice and lesions in the retina of <i>Ccm2</i>^<i>ECKO</i> mice. by Jia Li (160557)

Treatment with low doses of GI254023X causes a mild decrease in ADAM10 surface expression that correlates with a marked impairment of HCV infectivity. by Belén Carriquí-Madroñal (17396512)

Pre-exposure to mRNA-LNPs decreases antigen levels. by Zhen Qin (411748)

Effects of 254- or 222-UVC exposure on <i>C</i>. <i>elegans</i> motility. by Kaoru Okamoto Yoshiyama (14526661)

Subjects:

Impact of CMS121 and C75 on HSV-1 entry into Vero cells. by Camilla Albano (16446679)